Non-ICANS neurotoxicities CD19-directed CAR T-cell therapy and the emergence of movement and neurocognitive treatment-emergent adverse events: a case report.

Saved in:
Bibliographic Details
Title: Non-ICANS neurotoxicities CD19-directed CAR T-cell therapy and the emergence of movement and neurocognitive treatment-emergent adverse events: a case report.
Authors: Schroeder T; Department of Medicine II, Department of Haematology and Oncology, University Hospital Schleswig-Holstein Kiel, Kiel University, Kiel, Germany., Chitadze G; Department of Medicine II, Department of Haematology and Oncology, University Hospital Schleswig-Holstein Kiel, Kiel University, Kiel, Germany., Dargvainiene J; Institute of Clinical Chemistry, University Hospital Schleswig-Holstein Kiel, Kiel University, Kiel, Germany., Martens T; Department of Medicine II, Department of Haematology and Oncology, University Hospital Schleswig-Holstein Kiel, Kiel University, Kiel, Germany., Gebauer N; Department of Haematology and Oncology, University Hospital Schleswig-Holstein Lübeck, University of Lübeck, Lübeck, Germany., Frimmel J; Department of Medicine II, Department of Haematology and Oncology, University Hospital Schleswig-Holstein Kiel, Kiel University, Kiel, Germany., Brüggemann M; Department of Medicine II, Department of Haematology and Oncology, University Hospital Schleswig-Holstein Kiel, Kiel University, Kiel, Germany., Valerius T; Department of Medicine II, Department of Haematology and Oncology, University Hospital Schleswig-Holstein Kiel, Kiel University, Kiel, Germany., Schub N; Department of Medicine II, Department of Haematology and Oncology, University Hospital Schleswig-Holstein Kiel, Kiel University, Kiel, Germany., Baldus CD; Department of Medicine II, Department of Haematology and Oncology, University Hospital Schleswig-Holstein Kiel, Kiel University, Kiel, Germany., Pott C; Department of Medicine II, Department of Haematology and Oncology, University Hospital Schleswig-Holstein Kiel, Kiel University, Kiel, Germany., Leypoldt F; Institute of Clinical Chemistry, University Hospital Schleswig-Holstein Kiel, Kiel University, Kiel, Germany.; Department of Neurology, University Hospital Schleswig-Holstein Kiel, Kiel University, Kiel, Germany., Stürner K; Department of Neurology, University Hospital Schleswig-Holstein Kiel, Kiel University, Kiel, Germany., Stölzel F; Department of Medicine II, Department of Haematology and Oncology, University Hospital Schleswig-Holstein Kiel, Kiel University, Kiel, Germany.
Source: Frontiers in immunology [Front Immunol] 2026 Feb 16; Vol. 17, pp. 1749587. Date of Electronic Publication: 2026 Feb 16 (Print Publication: 2026).
Publication Type: Case Reports; Journal Article
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41777880
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Non-ICANS neurotoxicities CD19-directed CAR T-cell therapy and the emergence of movement and neurocognitive treatment-emergent adverse events: a case report.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Schroeder+T%22">Schroeder T</searchLink>; Department of Medicine II, Department of Haematology and Oncology, University Hospital Schleswig-Holstein Kiel, Kiel University, Kiel, Germany.<br /><searchLink fieldCode="AU" term="%22Chitadze+G%22">Chitadze G</searchLink>; Department of Medicine II, Department of Haematology and Oncology, University Hospital Schleswig-Holstein Kiel, Kiel University, Kiel, Germany.<br /><searchLink fieldCode="AU" term="%22Dargvainiene+J%22">Dargvainiene J</searchLink>; Institute of Clinical Chemistry, University Hospital Schleswig-Holstein Kiel, Kiel University, Kiel, Germany.<br /><searchLink fieldCode="AU" term="%22Martens+T%22">Martens T</searchLink>; Department of Medicine II, Department of Haematology and Oncology, University Hospital Schleswig-Holstein Kiel, Kiel University, Kiel, Germany.<br /><searchLink fieldCode="AU" term="%22Gebauer+N%22">Gebauer N</searchLink>; Department of Haematology and Oncology, University Hospital Schleswig-Holstein Lübeck, University of Lübeck, Lübeck, Germany.<br /><searchLink fieldCode="AU" term="%22Frimmel+J%22">Frimmel J</searchLink>; Department of Medicine II, Department of Haematology and Oncology, University Hospital Schleswig-Holstein Kiel, Kiel University, Kiel, Germany.<br /><searchLink fieldCode="AU" term="%22Brüggemann+M%22">Brüggemann M</searchLink>; Department of Medicine II, Department of Haematology and Oncology, University Hospital Schleswig-Holstein Kiel, Kiel University, Kiel, Germany.<br /><searchLink fieldCode="AU" term="%22Valerius+T%22">Valerius T</searchLink>; Department of Medicine II, Department of Haematology and Oncology, University Hospital Schleswig-Holstein Kiel, Kiel University, Kiel, Germany.<br /><searchLink fieldCode="AU" term="%22Schub+N%22">Schub N</searchLink>; Department of Medicine II, Department of Haematology and Oncology, University Hospital Schleswig-Holstein Kiel, Kiel University, Kiel, Germany.<br /><searchLink fieldCode="AU" term="%22Baldus+CD%22">Baldus CD</searchLink>; Department of Medicine II, Department of Haematology and Oncology, University Hospital Schleswig-Holstein Kiel, Kiel University, Kiel, Germany.<br /><searchLink fieldCode="AU" term="%22Pott+C%22">Pott C</searchLink>; Department of Medicine II, Department of Haematology and Oncology, University Hospital Schleswig-Holstein Kiel, Kiel University, Kiel, Germany.<br /><searchLink fieldCode="AU" term="%22Leypoldt+F%22">Leypoldt F</searchLink>; Institute of Clinical Chemistry, University Hospital Schleswig-Holstein Kiel, Kiel University, Kiel, Germany.; Department of Neurology, University Hospital Schleswig-Holstein Kiel, Kiel University, Kiel, Germany.<br /><searchLink fieldCode="AU" term="%22Stürner+K%22">Stürner K</searchLink>; Department of Neurology, University Hospital Schleswig-Holstein Kiel, Kiel University, Kiel, Germany.<br /><searchLink fieldCode="AU" term="%22Stölzel+F%22">Stölzel F</searchLink>; Department of Medicine II, Department of Haematology and Oncology, University Hospital Schleswig-Holstein Kiel, Kiel University, Kiel, Germany.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101560960%22">Frontiers in immunology</searchLink> [Front Immunol] 2026 Feb 16; Vol. 17, pp. 1749587. <i>Date of Electronic Publication: </i>2026 Feb 16 (<i>Print Publication: </i>2026).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Case Reports; Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101560960 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1664-3224 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216643224%22">16643224 </searchLink><i>NLM ISO Abbreviation: </i>Front Immunol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41777880
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fimmu.2026.1749587
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1749587
    Titles:
      – TitleFull: Non-ICANS neurotoxicities CD19-directed CAR T-cell therapy and the emergence of movement and neurocognitive treatment-emergent adverse events: a case report.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Schroeder T
      – PersonEntity:
          Name:
            NameFull: Chitadze G
      – PersonEntity:
          Name:
            NameFull: Dargvainiene J
      – PersonEntity:
          Name:
            NameFull: Martens T
      – PersonEntity:
          Name:
            NameFull: Gebauer N
      – PersonEntity:
          Name:
            NameFull: Frimmel J
      – PersonEntity:
          Name:
            NameFull: Brüggemann M
      – PersonEntity:
          Name:
            NameFull: Valerius T
      – PersonEntity:
          Name:
            NameFull: Schub N
      – PersonEntity:
          Name:
            NameFull: Baldus CD
      – PersonEntity:
          Name:
            NameFull: Pott C
      – PersonEntity:
          Name:
            NameFull: Leypoldt F
      – PersonEntity:
          Name:
            NameFull: Stürner K
      – PersonEntity:
          Name:
            NameFull: Stölzel F
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 16
              M: 02
              Text: 2026 Feb 16
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1664-3224
          Numbering:
            – Type: volume
              Value: 17
          Titles:
            – TitleFull: Frontiers in immunology
              Type: main
ResultId 1